| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
| ||||||||||||||||||||||||||||||||
Departments of 1 Internal Medicine
2 Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut.
Address correspondence to Thomas M. Gill, MD, Yale University School of Medicine, Dorothy Adler Geriatric Assessment Center, 20 York Street, New Haven, CT 06504. E-mail: gill{at}ynhh.org
| Abstract |
|---|
|
|
|---|
Methods. Participants included 754 initially nondisabled community-dwelling persons, aged 70 years or older, who were interviewed monthly for 4 years to ascertain ADL disability. Estimates of active and disabled life expectancy were calculated using an incrementdecrement life table for assessment intervals of 1 month, 1 year, and 2 years.
Results. For each of five age groups, the monthly assessment strategy yielded the highest values for active life expectancy and the lowest values for disabled life expectancy. The 95% confidence intervals for these values, however, overlapped the corresponding point estimates for the annual and biennial strategies.
Conclusions. Accurate estimates of active and disabled life expectancy may be obtained from epidemiologic studies that assess ADL function no more frequently than every other year.
The objective of the current study was to compare estimates of active and disabled life expectancy based on traditional assessment intervals of 1 or 2 years with those based on more frequent assessments at 1-month intervals. We used data from a unique longitudinal study that includes monthly assessments of ADL function for 4 years among a large cohort of community-dwelling older persons, with little missing data and few losses to follow-up.
| METHODS |
|---|
|
|
|---|
Data Collection
The baseline assessments were completed by trained research nurses using standard instruments. Data were collected on demographic characteristics, cognitive status as assessed by the Mini-Mental State Examination (12), and 13 self-reported, physician-diagnosed chronic conditions: hypertension; myocardial infarction; congestive heart failure; stroke; diabetes; arthritis; hip fracture; fracture of wrist, arm, or spine since age 50; amputation of leg; chronic lung disease; cirrhosis or liver disease; cancer (other than minor skin cancers); and Parkinson's disease. Collection of these baseline data was 100% complete.
Complete details regarding the assessment of disability, including formal tests of reliability and accuracy, are provided elsewhere (8). During monthly telephone interviews, participants were assessed for disability using standard questions that were identical to those used during the screening telephone interview (8). For each of the four key ADLs, we asked, "At the present time, do you need help from another person to (complete the task)?" Participants who needed help with any of the tasks were considered to be disabled. Conversely, those who did not need help were considered to be nondisabled (or independent). Participants were not asked about eating, toileting, or grooming. The incidence of disability in these three ADLs is low among nondisabled, community-dwelling older persons (13,14). Furthermore, it is highly uncommon for disability to develop in these ADLs without concurrent disability in bathing, dressing, walking, or transferring (1315). Among a subgroup of 91 participants who were interviewed twice within a 2-day period by different interviewers, we found that the reliability of our disability assessment was substantial (16), with Kappa = 0.75 for disability in one or more of the four ADLs. Kappa was 1.0 for the 18 paired interviews that were completed independently by different interviewers on the same day. For participants with significant cognitive impairment, the monthly telephone interviews were completed with a designated proxy. The accuracy of these proxy reports for disability, compared to reports from cognitively intact participants, was excellent, with Kappa = 1.0 (8). Deaths were ascertained by review of the local obituaries and/or from an informant during a subsequent telephone interview.
Statistical Analysis
We calculated active and disabled life expectancy using incrementdecrement life tables (2,5,17). Because age is the strongest demographic determinant of disability and life expectancy, we report results separately for the following five age groups: 7074 years, 7579 years, 8084 years, 8589 years, and 90 years or older. We do not report results separately for men and women because of stochastic variability inherent in small samples and because our intent was not to calculate population-based estimates of active and disabled life expectancy, but rather to compare estimates using different assessment intervals. We chose not to model transitions between the four possible states (independence, disability, death, and missing) as a Markov chain because recent evidence suggests that the underlying assumption regarding independence of transitions over time may not be valid (11). Also, our sample size was not sufficiently large to implement a Markov chain model for the resulting 16 possible transitions for each of the five age groups.
We calculated mortality rates and probabilities of independence and disability for each age group using an incidence-density approach. For the monthly assessment strategy, we counted the total number of deaths and person-months during each year of follow-up, computed mortality rates per person-month, converted these results to annual mortality rates, and entered these rates into the incrementdecrement life table to compute age-specific probabilities of death and, subsequently, life expectancy (17). Next, during each year of follow-up we counted the total number of months of independence and disability, respectively, and divided these results by the total number of person-months. These proportions were subsequently used to partition total life expectancy into active life expectancy and disabled life expectancy in the incrementdecrement life table. The aforementioned procedures allowed us to simultaneously account for the effects of advancing age and time. For example, a participant who was 73 years at baseline and had 4 years of follow-up would contribute 2 person-years to each of the first (7074 years) and second (7579 years) age groups.
For the annual assessment strategy, we assumed that participants were interviewed only every 12 months, so that independence or disability was determined each year based solely on the interviews completed at months 12, 24, 36, and 48, respectively. If a participant was disabled (or independent) at month 12, for example, he or she was considered to be disabled (or independent) for all 12 months during the prior year (5). For nondecedents who did not complete an annual interview (<1% for each), ADL status for the prior year was set to missing. Decedents received no credit towards active or disabled life expectancy for the time from the last completed annual interview to the time of death (6). A similar set of procedures was used for the biennial assessment strategy except that independence or disability was determined every other year based solely on the interviews completed at months 24 and 48, respectively. When calculating the age-specific probabilities of death, the time from the last completed annual (or biennial) interview to the time of death was not included in the denominator to ensure that life expectancy equaled the sum of active and disabled life expectancy (5). We chose not to estimate active and disabled life expectancy from a single 4-year interval for two reasons. First, an incrementdecrement life table cannot be implemented from only a single transition. Second, most prior studies have included assessment intervals of 12 years (14).
Because the incrementdecrement life table method does not provide estimates of variance, we used bootstrapping methodology, as suggested by Land and colleagues (5), to calculate 95% confidence intervals for active and disabled life expectancy. We generated 1000 pseudo-samples of 754 participants, calculated an incrementdecrement life table for each sample, and computed means and 95% confidence intervals based on the observed upper and lower 2.5% tails from each of the distributions. The 95% confidence intervals were used to compare the estimates of active and disabled life expectancy for the different assessment strategies. Customized code was written to construct the incrementdecrement life tables and bootstrapped samples using SAS version 8.2 (18).
| RESULTS |
|---|
|
|
|---|
|
|
| DISCUSSION |
|---|
|
|
|---|
Accurate estimates of active and disabled life expectancy are important for forecasting future medical and long-term care costs and for planning effectively for services to meet the future needs of older Americans (3,19). Estimates of active and disabled life expectancy were originally calculated using a single-decrement table, which treated disability as a permanent condition (1), but are now routinely calculated using more sophisticated multistate methods (2,4,17), which allow for the possibility of recovery from disability. Nonetheless, most analytic strategies for estimating active life expectancy have assumed stability in ADL function between periodic surveys spanning 1224 months (14). Because this assumption is no longer tenable (8,9), we set out in the current study to compare estimates of active and disabled life expectancy based on traditional assessment intervals of 1 or 2 years with those based on more frequent assessments at 1-month intervals. Our "null" findings bolster the validity of current estimates of active and disabled life expectancy and suggest that ADL function need not be assessed more frequently than every other year to yield accurate estimates. While periodic surveys spanning 1224 months will undoubtedly miss many intermittent episodes of disability, this "undercounting" appears to be more than offset by "overcounting" when disability is presumed to persist for the duration of the 12- to 24-month assessment interval. This phenomenon is shown in Table 3, which provides data on the number of person-months of disability for assessment intervals of 1 month and 1 year. At each year of follow-up, disability for the 1-year assessment interval is undercounted because participants who are independent, dead, or missing at the annual assessment accrue no person-months of disability, and is overcounted because participants who are disabled at the annual assessment accrue 12 months of disability.
|
We recognize potential limitations to our study. First, disability at baseline was an exclusion criterion. When we reran our analyses, using the 12-month interview as "baseline" (prevalence of disability = 10.2%), our results did not change appreciably (data available upon request). Second, our participants were members of a single health plan in a small urban area. According to the 2000 census (http://factfinder.census.gov), the demographic characteristics of persons aged 65 years or older are comparable for New Haven county and the United States, with the exception of race. New Haven county has a larger proportion of non-Hispanic whites relative to the United States (91.1% vs 83.7%). Despite this modest difference, we can think of no reason why our null findings should not be applicable to other populations of older persons. Third, eating, toileting, and grooming were omitted from our disability assessment. Although these omissions could lead to an underestimate of disability severity, they would have had little effect on our ascertainment of disability and, hence, on our estimates of active and disabled life expectancy. Indeed, despite the exclusion of persons who were nondisabled at baseline, our age-specific estimates of active life expectancy are only modestly higher than those that have been reported in three distinct populations of community-dwelling older persons, each of which included persons with disability at baseline (2).
Our study included monthly assessments of ADL function for 4 years on a large cohort of community-dwelling older persons, with a high participation rate, little missing data, and few losses to follow-up. To our knowledge, comparable data are available in no other study. Based on our results, we conclude that accurate estimates of active and disabled life expectancy may be obtained from epidemiologic studies that assess ADL function at intervals as long as 1224 months.
| Acknowledgments |
|---|
We thank Denise Shepard, BSN, MBA, Shirley Hannan, RN, Andrea Benjamin, BSN, Martha Oravetz, RN, Alice Kossack, Barbara Foster, Shari Lani, Alice Van Wie, and the late Bernice Hebert, RN, for assistance with data collection; Evelyne Gahbauer, MD, MPH, for data management and programming; Wanda Carr and Geraldine Hawthorne for assistance with data entry and management; Peter Charpentier, MPH, for development of the participant tracking system; and Joanne McGloin, MDiv, MBA, for leadership and advice as the Project Director.
| Footnotes |
|---|
Received April 13, 2004
Accepted May 7, 2004
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. M. Gill and E. A. Gahbauer Evaluating Disability Over Discrete Periods of Time J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2008; 63(6): 588 - 594. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||
| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|